SUMER JACQUELYN L
Insider CIK 1844824 · GNCA CHIEF LEGAL & COMPLIANCE OFF · CGEM Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics, Inc | A Award | 2026-06-30 | 2026-07-02 | 2,470 | $8.60 | $21.2K | 130,559 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | S Sale | 2026-02-24 | 2026-02-25 | 3,601 | $14.47 | $52.1K | 128,089 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | S Sale | 2026-02-20 | 2026-02-23 | 3,742 | $13.62 | $51.0K | 131,690 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2026-02-18 | 2026-02-19 | 230,000 | — | $0 | 230,000 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | S Sale | 2025-12-18 | 2025-12-19 | 3,480 | $9.67 | $33.7K | 135,432 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | S Sale | 2025-02-25 | 2025-02-27 | 3,756 | $8.53 | $32.0K | 136,895 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2025-02-19 | 2025-02-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | A Award | 2025-02-19 | 2025-02-21 | 50,000 | — | $0 | 140,651 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | S Sale | 2024-12-18 | 2024-12-20 | 3,482 | $11.41 | $39.7K | 90,651 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award deriv | 2024-02-22 | 2024-02-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award | 2024-02-22 | 2024-02-23 | 50,000 | — | $0 | 94,133 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2023-12-21 | 2023-12-22 | 1,400 | $8.50 | $11.9K | 44,133 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2023-12-18 | 2023-12-20 | 290 | $8.22 | $2.4K | 45,533 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2023-06-20 | 2023-06-21 | 291 | $12.94 | $3.8K | 45,823 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2023-05-18 | 2023-05-19 | 291 | $8.76 | $2.5K | 46,114 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2023-04-18 | 2023-04-20 | 290 | $10.71 | $3.1K | 46,405 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2023-03-20 | 2023-03-27 | 305 | $11.32 | $3.5K | 46,695 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award deriv | 2023-02-17 | 2023-02-21 | 93,500 | — | $0 | 93,500 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award | 2023-02-17 | 2023-02-21 | 47,000 | — | $0 | 47,000 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award deriv | 2022-08-15 | 2022-08-16 | 190,000 | — | $0 | 190,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-06-01 | 2022-06-02 | 2,500 | $0.06 | $150 | 43,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2022-03-15 | 2022-03-17 | 112,500 | — | $0 | 112,500 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award | 2022-03-15 | 2022-03-17 | 37,500 | — | $0 | 45,500 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2021-03-15 | 2021-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2021-03-01 | 2021-03-02 | 115,000 | $3.07 | $353.1K | 115,000 | SEC↗ |